Denis Boulay

1.2k total citations
23 papers, 816 citations indexed

About

Denis Boulay is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, Denis Boulay has authored 23 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 5 papers in Social Psychology. Recurrent topics in Denis Boulay's work include Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Receptor Mechanisms and Signaling (11 papers). Denis Boulay is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Receptor Mechanisms and Signaling (11 papers). Denis Boulay collaborates with scholars based in France, United States and Morocco. Denis Boulay's co-authors include Guy Griebel, Ronan Depoortère, D. J. Sanger, Olivier Bergis, Philippe Pichat, Jeanne Stemmelin, Emiliana Borrelli, Gh. Perrault, Caroline Louis and Ghislaine Perrault and has published in prestigious journals such as Scientific Reports, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

In The Last Decade

Denis Boulay

23 papers receiving 797 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Denis Boulay	587	410	96	83	80	23	816
Keiko Ikemoto	504 0.9×	335 0.8×	64 0.7×	81 1.0×	51 0.6×	63	853
Tereza Smejkalová	562 1.0×	394 1.0×	94 1.0×	87 1.0×	82 1.0×	25	1.0k
Hideko Yamamoto	794 1.4×	588 1.4×	65 0.7×	139 1.7×	97 1.2×	50	1.2k
Aleš Balík	468 0.8×	542 1.3×	90 0.9×	83 1.0×	66 0.8×	34	1.1k
Jun’ichi Semba	508 0.9×	376 0.9×	67 0.7×	101 1.2×	76 0.9×	42	897
Audrey Hashim	695 1.2×	503 1.2×	37 0.4×	93 1.1×	59 0.7×	36	948
Ratna Sircar	857 1.5×	439 1.1×	129 1.3×	206 2.5×	66 0.8×	43	1.0k
Rina Murai	441 0.8×	373 0.9×	89 0.9×	122 1.5×	61 0.8×	10	780
Olivier Bergis	432 0.7×	408 1.0×	74 0.8×	137 1.7×	185 2.3×	19	788
Philippe Pichat	424 0.7×	448 1.1×	73 0.8×	125 1.5×	206 2.6×	26	981

Countries citing papers authored by Denis Boulay

Since Specialization

Citations

This map shows the geographic impact of Denis Boulay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Boulay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Boulay more than expected).

Fields of papers citing papers by Denis Boulay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Boulay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Boulay. The network helps show where Denis Boulay may publish in the future.

Co-authorship network of co-authors of Denis Boulay

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Boulay. A scholar is included among the top collaborators of Denis Boulay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Boulay. Denis Boulay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chemello, Kévin, Sandra Beeské, Thi Thu Trang Tran, et al.. (2020). Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With Alirocumab. JACC Basic to Translational Science. 5(6). 549–557. 19 indexed citations

Griebel, Guy, Jeanne Stemmelin, Mati Lopez‐Grancha, et al.. (2019). The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents. Scientific Reports. 9(1). 18045–18045. 77 indexed citations

Griebel, Guy, Philippe Pichat, Denis Boulay, et al.. (2016). The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia. Scientific Reports. 6(1). 35320–35320. 40 indexed citations

Boulay, Denis, et al.. (2013). Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats. Behavioural Pharmacology. 24(7). 543–551. 22 indexed citations

Millan, Mark J., Denis Boulay, Guy Griebel, et al.. (2013). CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents. Psychopharmacology. 231(7). 1289–1303. 2 indexed citations

Boulay, Denis, et al.. (2010). SSR181507, a dopamine D2 receptor and 5-HT1A receptor ligand: Evidence for mixed anxiolytic- and antidepressant-like activities. Pharmacology Biochemistry and Behavior. 97(3). 428–435. 7 indexed citations

Boulay, Denis, Olivier Bergis, Patrick Avenet, & Guy Griebel. (2009). The Glycine Transporter-1 Inhibitor SSR103800 Displays a Selective and Specific Antipsychotic-like Profile in Normal and Transgenic Mice. Neuropsychopharmacology. 35(2). 416–427. 37 indexed citations

Black, Mark D., Geoffrey B. Varty, Michal Arad, et al.. (2008). Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology. 202(1-3). 385–396. 68 indexed citations

Boulay, Denis, Philippe Pichat, Gihad Dargazanli, et al.. (2008). Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia☆. Pharmacology Biochemistry and Behavior. 91(1). 47–58. 71 indexed citations

10.

Louis, Caroline, Jeanne Stemmelin, Denis Boulay, et al.. (2007). Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models. Pharmacology Biochemistry and Behavior. 89(1). 36–45. 43 indexed citations

11.

Boulay, Denis, Ronan Depoortère, Caroline Louis, et al.. (2004). SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats. Neuropharmacology. 46(8). 1121–1129. 46 indexed citations

12.

Depoortère, Ronan, Denis Boulay, Ghislaine Perrault, et al.. (2003). SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity. Neuropsychopharmacology. 28(11). 1889–1902. 48 indexed citations

13.

Naudon, Laurent, Isabelle Leroux‐Nicollet, Denis Boulay, & Jean Costentin. (2001). Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum. Journal of Neural Transmission. 108(4). 431–444. 4 indexed citations

14.

Boulay, Denis, et al.. (2000). Haloperidol-induced catalepsy is absent in dopamine D2, but maintained in dopamine D3 receptor knock-out mice. European Journal of Pharmacology. 391(1-2). 63–73. 59 indexed citations

15.

Boulay, Denis, et al.. (2000). Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule of the cerebellum: A D3 receptor mediated effect?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 24(1). 39–49. 14 indexed citations

16.

Boulay, Denis, Ronan Depoortère, Gh. Perrault, Emiliana Borrelli, & D. J. Sanger. (1999). Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. Neuropharmacology. 38(9). 1389–1396. 97 indexed citations

17.

Boulay, Denis, Dominique Duterte‐Boucher, Isabelle Leroux‐Nicollet, Laurent Naudon, & Jean Costentin. (1996). Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 330–337. 32 indexed citations

18.

Boulay, Denis, Dominique Duterte‐Boucher, Dominique Nouel, & Jean Costentin. (1996). Locomotor sensitization to [d-Trp11]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats. Neuroscience Letters. 208(1). 5–8. 9 indexed citations

19.

Aubin, Jean‐Thierry, et al.. (1995). Evaluation of a new non-isotopic sandwich hybridization for the detection of HIV1-specific PCR products. Research in Virology. 146(1). 75–79. 5 indexed citations

20.

Boulay, Denis, Isabelle Leroux‐Nicollet, Dominique Duterte‐Boucher, Laurent Naudon, & Jean Costentin. (1994). Invariance of the density of dopamine uptake sites and dopamine metabolism in the rat brain after a chronic treatment with the dopamine uptake inhibitor GBR 12783. Journal of Neural Transmission. 98(3). 209–215. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact